120 Participants Needed

Jaspr Health App for Suicidal Thoughts

DM
AK
AR
AK
Overseen ByAngela Kelley Brimer, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Evidence-Based Practice Institute, Seattle, WA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests an app called WisePath, designed to assist individuals with suicidal thoughts who may also misuse alcohol. The goal is to determine if the app can support and guide users by providing tools and strategies to manage their feelings and behaviors. Participants will use either the WisePath app or a different self-help app with additional wellness resources. Individuals experiencing suicidal thoughts or who have attempted suicide in the past, particularly if alcohol misuse is a concern, might be well-suited for this trial. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative mental health solutions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that the Jaspr Health App is safe for individuals with suicidal thoughts?

Research shows that the WisePath app, tested in this trial, uses proven methods for preventing suicide. These methods have been shown to reduce suicidal thoughts and actions. The app is designed to assist individuals dealing with depression, thoughts of self-harm, and alcohol problems.

WisePath offers tools such as safety plans and strategies for coping with difficult feelings. Although specific safety data from large studies is not yet available, the app is based on methods known to be effective and safe. This suggests that most people are likely to use WisePath without issues.

Even without specific safety data, digital mental health tools like WisePath are generally safe and non-invasive. They provide support without the physical risks associated with medication or surgery. If there are any concerns about using the app, consulting a healthcare provider is advisable.12345

Why are researchers excited about this trial?

Unlike traditional approaches for managing suicidal thoughts, which often rely on in-person therapy or medication, the Jaspr2.0 app offers a digital, self-guided alternative. Researchers are excited about WisePath, the app's component, because it provides users with immediate access to tools like safety planning and strategies to manage distressing feelings. This innovative delivery method empowers individuals to engage in proactive self-help anytime, which can be crucial during moments of crisis. Additionally, the integration of comprehensive wellness resources and psychoeducation sets this app apart, potentially offering a more holistic approach to mental health support.

What evidence suggests that the WisePath app is effective for reducing suicidality and alcohol misuse?

Research has shown that Jaspr Health, the technology behind the WisePath app, effectively reduces suicidal thoughts and behaviors. Participants in this trial may use the WisePath app, which has proven effective in emergency room settings, suggesting it can assist during critical times. The app employs methods that enhance outcomes in healthcare systems and supports the Zero Suicide approach, which has improved patient safety and mental health. Although more information is always beneficial, early results are promising for those dealing with suicidal thoughts and related issues.678910

Who Is on the Research Team?

LA

Linda A. Dimeff, PhD

Principal Investigator

Chief Executive Officer

Are You a Good Fit for This Trial?

Adults over 18 with suicidal thoughts, who have seen their primary care provider in the past year, use a smartphone with data, and may misuse alcohol can join. Those with severe depression or alcohol dependence, acute suicidal tendencies, or significant drug abuse cannot participate.

Inclusion Criteria

Scores 1 or greater on Item 9 of the Patient Health Questionnaire-9 (PHQ-9)
To ensure a sufficient sample of individuals who misuse alcohol, no fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking.
English speaking
See 2 more

Exclusion Criteria

You are currently feeling very suicidal or have had recent thoughts of hurting yourself.
I have severe depression based on my PHQ-9 score.
Alcohol dependence (AUDIT score of 15 or greater)
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (virtual)

Treatment

Participants are randomly assigned to either the WisePath app or an active control condition for 12 weeks

12 weeks
4 assessments (virtual) at baseline, 4, 8, and 12 weeks

Follow-up

Participants are monitored for changes in suicidal ideation, alcohol misuse, and other behavioral health concerns

4 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Active-Control app + electronic wellness resources brochure
  • Jaspr2.0
Trial Overview The trial is testing Jaspr2.0 app against an active control (Virtual Hope Box + wellness resources) for helping adults manage suicidal ideation and alcohol misuse. It's a randomized study assessing participants at multiple points over 12 weeks.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: WisePath for AdultsExperimental Treatment1 Intervention
Group II: Active-Control app + electronic wellness resources brochureActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Evidence-Based Practice Institute, Seattle, WA

Lead Sponsor

Trials
9
Recruited
29,800+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Published Research Related to This Trial

The mobile app developed as part of the SERO suicide prevention program aims to reduce suicides and suicide attempts by enhancing self-management for individuals at risk, incorporating strategies like safety planning and mood tracking.
The app's design was informed by collaboration among health professionals, individuals at risk, and their families, ensuring it addresses real needs and integrates essential suicide prevention strategies effectively.
SERO - A New Mobile App for Suicide Prevention.Meier, L., Gurtner, C., Nuessli, S., et al.[2022]
The study evaluated the feasibility of two mental health apps, BackUp and mEMA, for treating depressed outpatients with suicidal ideation, involving 17 participants over a 3-month period.
Both apps were found to be usable and acceptable, scoring above the thresholds for usability and satisfaction, but the study did not meet the criteria for sufficient uptake, indicating that further exploration is needed for integrating these apps into routine mental healthcare.
The feasibility of using smartphone apps as treatment components for depressed suicidal outpatients.Nuij, C., van Ballegooijen, W., de Beurs, D., et al.[2023]
A review of 43 suicide prevention apps available on the Android platform for Indian users revealed that less than half included evidence-based content, highlighting a gap in the reliability of information provided to users.
While most apps offered regional suicide helpline numbers, only a small percentage included motivational prompts to encourage users to reach out for help, indicating a need for improvement in app design to enhance user engagement and support.
Suicide Prevention Mobile Apps for Indian Users: An Overview.Sudarshan, S., Mehrotra, S.[2021]

Citations

Efficacy, Effectiveness, and Implementation of Jaspr Health ...This study will evaluate Jaspr's patient-facing tablet-based application (app) during suicide-related ED visits. The app guides patients in completing the ...
Using a Tablet-Based App to Deliver Evidence ...Even with limited statistical power, the results showed that Jaspr Health is feasible, acceptable, and clinically effective for use by ED ...
Preliminary Findings from Jaspr Health Clinical Trial74% of the sample had made a suicide attempt in their lifetime (M=3.4; SD=6.4); 61% engaged in non-suicidal self-injurious behaviors over their lifetime at an ...
Jaspr Health Digital Platform - EDC Solutionsโ€œData are clear that when you implement a Zero Suicide framework, you improve outcomes. Jaspr's evidence-based digital technology helps health systems ...
A Suicide Prevention Digital Technology for Individuals ...This study evaluates the safety and effectiveness of an evidence-based digital technology (Jaspr Health) designed for persons with acute suicidal ideation.
Unlocking Digital Pathways to Improving Adolescent ...The prevalence of behavioral health concerns among teens in the U.S. has reached alarming levels. Studies show that one in five adolescents experiences a mental ...
Provider Perspectives on the Use of Mental Health Apps, and ...Adolescent suicidal behavior, suicide ideation, and depression are major public health problems that have increased significantly over the past ...
a systematic assessment of adherence to clinical guidelinesWe assessed adherence of suicide prevention advice in depression management and suicide prevention apps to six evidence-based clinical guideline ...
9.hopeline-nc.orghopeline-nc.org/
Crisis Intervention | HopeLineHopeLine offers caring, non-judgmental listening, crisis intervention and suicide prevention available over the phone or by text.
NCT05427734 | Drivers of Suicide Mobile App StudyWisePath will include evidence-based practices for suicide prevention, including for those who are suicidal and also experience other behavioral health concerns ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity